Ethyl N-(tert-Butoxycarbonyl)-L-pyroglutamate>97.0%(HPLC)(N)1g

2-(methoxymethyl)-5-methyl-1H-benzimidazole, 95.0%, 1g

(E)-4-(2,4-Dichloro-phenyl)-but-3-en-2-one, 95.0%, 5g

(S)-(9H-Fluoren-9-yl)methyl (1-oxo-5-(3-((2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-yl)sulfonyl)guanidino)pentan-2-yl)carbamate, 98%, 1g

4-[7,12,17-tris(4-chlorophenyl)-21,22,23,24-tetraazapentacyclo[16.2.1.1�,?.1?,��.1��,�?]tetracosa-1,3,5,7,9,11,13(22),14,16,18(21),19-undecaen-2-yl]phenol, 95%, 1g

6-Chloro-5-nitro-1H-indazole, 95.0%, 250mg

3-AMINO-4-CYCLOHEXYL-BENZOIC ACID METHYL ESTER, 95.0%, 500mg

(4R)-4-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-1-METHYL-D-PROLINE, 95.0%, 1g

2-Thiophenesulfonamide, N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-, 98%, 5mg

4-(1H-imidazol-4-yl)pyridine, 97%, 100mg

5-(Aminomethyl)-2-chlorobenzoic acid, 98%, 5g

2-Bromophenanthrene>97.0%(GC)200mg

2-Fluoro-5-methyl-4-nitrophenol, 98%, 5g